Boiron (LTS:0DTF) Short Interest


LTS:0DTF Boiron SA LTS:0DTF
73 GF Score
Price €27.70
GF Value €33.63
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Boiron Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0DTF vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Boiron's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boiron Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Boiron's Short Interest distribution charts can be found below:

* The bar in red indicates where Boiron's Short Interest falls into.


LTS:0DTF
73GF Score
Boiron SA LTS:0DTF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Boiron (LTS:0DTF) Overvalued in 2026?

Based on GuruFocus' analysis, Boiron stock appears to be undervalued. The current stock price of €27.70 is trading 17.6% below its estimated GF Value™ of €33.63. GuruFocus considers Boiron to be Modestly Undervalued.

Key valuation signals for LTS:0DTF:

  • Short Interest:
  • GF Value™: €33.63 vs. price of €27.70 (17.6% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the LTS:0DTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boiron Business Description

Address 2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
73GF Score

Get the complete analysis for LTS:0DTF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.70
Price
€33.63
GF Value